Loeb Partners Corp’s Compugen CGEN Stock Holding History

Loeb Partners Corp’s Portfolio CGEN Stock Details CGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-300	Closed	-$1K	–	32
2019 Q1	$1K	Hold	300	–	–	0.02%	121
2018 Q4	$1K	Buy	+300	New	+$950	﹤0.01%	289

Other funds holding CGEN

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RIL

Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return

Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Loeb Partners Corp's CGEN Position: Q2 2019 in Review

Loeb Partners Corp sold out of Compugen (CGEN) in Q2 2019, closing a stake of 300 shares — an estimated $1K sold.

Loeb Partners Corp first reported a position in CGEN in Q4 2018 and held it in 2 quarters. The position peaked at $1K in Q1 2019. 41 funds tracked by Wall St. Rank hold CGEN as of Q2 2019.

Loeb Partners Corp reported no remaining Compugen position as of Q2 2019 after selling out during the quarter.
Loeb Partners Corp sold 300 Compugen shares in Q2 2019, an estimated $1K.
Loeb Partners Corp first reported a position in Compugen in Q4 2018 and held it in 2 quarters.
Loeb Partners Corp's Compugen position peaked at $1K in Q1 2019.
41 funds tracked by Wall St. Rank held Compugen as of Q2 2019.

Based on Loeb Partners Corp's 13F filing for Q2 2019.